What Longevity Costs Data Shows About Longevity Clinic Pricing in 2026

The strongest signal from the Longevity Costs homepage is positioning. It describes itself as independent comparison research for NAD+ therapy, IV therapy, TRT/HRT clinics, and longevity programs, with methodology and disclaimers built into the experience.

The visible homepage metrics matter because they tell users what the directory wants to compete on: 28 providers tracked, a lowest starting price of $25, and 5 full-spectrum clinics. Those numbers give the site a data-led entry point rather than a purely editorial one.

It also segments the experience into therapy front doors such as providers, best NAD+ therapy, IV therapy cost, TRT cost, and peptides.

The sitemap is where the size of the project becomes clearer. Based on the live sitemap fetched on April 25, 2026, the site exposes 69 provider URLs, 575 comparison URLs, 125 near-me URLs, 6 calculator URLs, and 9 blog URLs. That is a much deeper footprint than the homepage alone suggests.

This is important because comparison sites live or die on coverage. A directory with provider pages only is useful, but a directory with provider pages, comparison pages, calculators, blog guides, and state-level discovery pages is trying to own multiple layers of user intent at once.

That architecture also helps explain why the site can support both high-level discovery and specific long-tail searches. Someone can start at Longevity Costs, then move to a provider page, a comparison page, a calculator, or a state landing page without leaving the site structure.

The public taxonomy is one of the most interesting parts of the data. Longevity Costs groups demand around NAD+, IV therapy, TRT/HRT, peptides, and broader longevity clinics rather than around one narrow intervention. That suggests shoppers are often comparing programs across adjacent therapies, not making isolated one-off decisions.

The homepage banners reinforce that behavior. NAD+ and IV therapy get their own front doors, while the provider grid includes hybrid clinics such as Lifeforce, Defy Medical, Ways2Well, Regenics, and Longevity Healthcare that span multiple treatment categories.

For anyone studying cash-pay health markets, that is a useful signal. The real competition is not only clinic versus clinic. It is also category versus category, membership versus one-off purchase, telehealth versus clinic-led care, and broad optimization platform versus single-treatment offering.

The calculator layer adds another important data signal. The sitemap lists calculator routes for TRT, IV therapy, peptides, hormone, full-stack planning, NAD cost, and a dedicated longevity spend calculator. That moves the site from static directory into budgeting workflow.

The editorial layer supports that same workflow. As of April 25, 2026, the sitemap includes articles on NAD+ therapy cost, IV therapy cost breakdowns, TRT clinic comparison, membership inclusions, and even a GLP-1 cost guide. That mix lets the site capture informational search intent and then route readers into transactional comparison pages.

From an SEO perspective, this is a classic but effective shape: money pages, comparison pages, calculators, and informational guides all reinforcing each other.

GLP-1 shoppers often overlap with buyers researching broader longevity, metabolic, or optimization spending. That is why Longevity Costs is worth watching even from a GLP-1-focused site. It shows how adjacent cash-pay health markets are packaged, priced, and compared online.

For readers here, the value is not that NAD+, IV therapy, TRT, or peptides are interchangeable with GLP-1 treatment. It is that they compete for the same discretionary health budget and are marketed with similar comparison language around memberships, telehealth, logistics, and monthly spend.

If you want to study that adjacent market directly, the cleanest starting points are the main providers directory, the calculators hub, and the Longevity Costs blog.